Celladon Receives Breakthrough Therapy Designation From FDA for MYDICAR
April 10, 2014 at 08:32 AM EDT
Celladon Corporation (Nasdaq: CLDN), a clinical-stage biotechnology company developing novel therapies for patients with heart failure ...